Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
about
4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with ObesityDiosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndromeBranched-chain amino acids in metabolic signalling and insulin resistanceTreating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbsImportance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitizationPharmacological effects of Trigonella foenum-graecum L. in health and disease.Early diabetic neuropathy: triggers and mechanisms.Study of lipid profile and parieto-temporal lipid peroxidation in AlCl₃ mediated neurotoxicity. Modulatory effect of fenugreek seeds.4-Hydroxyisoleucine improves hepatic insulin resistance by restoring glycogen synthesis in vitroRole of Fenugreek in the prevention of type 2 diabetes mellitus in prediabetes4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression.4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-α and regulating the expression of insulin signal transduction proteins.Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.Elicitation of Diosgenin Production in Trigonella foenum-graecum (Fenugreek) Seedlings by Methyl Jasmonate.Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized RatsHu-Lu-Ba-Wan Attenuates Diabetic Nephropathy in Type 2 Diabetic Rats through PKC- α /NADPH Oxidase Signaling PathwayNon-traditional therapies for diabetes: fact or fictionFenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration.Fenugreek increases insulin-stimulated creatine content in L6C11 muscle myotubes.4-Hydroxyisoleucine: A Potential New Treatment for Type 2 Diabetes Mellitus.A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion.Fenugreek seed extract treats peripheral neuropathy in pyridoxine induced neuropathic mice.Acute interaction between hydrocortisone and insulin alters the plasma metabolome in humansFenugreek supplementation during high-fat feeding improves specific markers of metabolic health4-Hydroxyisoleucine stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells via phosphatidylinositol-3-kinase-dependent pathway.Engineering a short-chain dehydrogenase/reductase for the stereoselective production of (2S,3R,4S)-4-hydroxyisoleucine with three asymmetric centers.Neuroprotective effect of RYGB in Zucker fatty diabetic rats.Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases.4-Hydroxyisoleucine production of recombinant Corynebacterium glutamicum ssp. lactofermentum under optimal corn steep liquor limitation.Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome.Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus
P2860
Q28072896-2B74BACF-00AB-4144-B821-332233142C7CQ28085501-FF88FA5A-3FBC-4F4D-83ED-71203B2C4F4FQ28249276-B36AEFDD-9763-4C4C-AF11-A139901D7702Q28687165-87802B75-EBC7-4C33-A5D2-D804E2C0D346Q33812148-7E980B56-628F-479D-B175-BE2B03CBA854Q35010855-568ED617-3819-44BA-84F2-8EE3D52A9225Q35691425-857219D0-2A4E-4D6B-A7CA-E9EA96DB07BFQ35811967-1978055F-FF83-4C70-A232-B8AB3CB8C25DQ35958812-46977C79-6778-4750-B8F3-24A6EA9BA2B6Q36114962-193F24A1-027E-4379-904A-8F7DA2969B9EQ36208394-DC569447-769C-4281-A07A-277E5BB6056AQ36224884-BBED383F-2588-4BB1-A7DD-BD919637931AQ36324890-AAFD2775-FA84-4DC4-8CCA-924731A43282Q36404309-DA5C9B52-5DDE-4EAF-8D67-49C226AA66ADQ36555977-38FF19A5-52C3-41DB-AAF8-77C53728245AQ37002867-5E5D8C41-9D1F-4CD4-A591-CD75D7741D58Q37021286-904B5C05-F3B9-48AB-9FD6-5F178B42A49FQ37301129-3F15CCB6-BDC9-46D3-8397-2FC9B68D8851Q38806389-BFCA0C07-1235-405E-90F2-691DB8E95F7CQ38827078-5748ED4B-F22F-44CE-AEF2-0FF17AAB0285Q38925632-875A8940-6D18-41A9-ACD9-618981B46EFDQ40488363-F9A59F6E-BB70-49ED-80AD-FD9E9673EAF2Q41125941-34FBA1A9-7B08-4E7E-A5CA-29F568D67A19Q42371769-E542EC78-69A0-45CD-8284-5B54A709B70BQ42506724-3B8BB386-F35D-443D-B99B-DC2F161A7C49Q42653344-828556D6-DFD0-4D99-A037-222468C21C6EQ43015815-8EE57F30-22A8-4A19-9AB4-77DEB23DC2D8Q43041205-49F694A7-2B7E-4F75-8C0E-504018765F7EQ51003633-D004BA43-39B6-4191-B5B1-838A2BE74B60Q55036636-5D867C5C-31CC-44E5-A0C4-EBAD4647114BQ57167981-27FD3006-A7CF-4BF2-B851-D42DAB5249CD
P2860
Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
@en
Insulinotropic agent ID-1101
@nl
type
label
Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
@en
Insulinotropic agent ID-1101
@nl
prefLabel
Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
@en
Insulinotropic agent ID-1101
@nl
P2093
P2860
P50
P1476
Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
@en
P2093
Alain Ktorza
Bernard Pau
Christine Rouault
Gérard Reach
Gérard Ribes
Michel Derouet
Michèle Manteghetti
Pierre Petit
Salwa Rizkalla
Vincent Breil
P2860
P304
P356
10.1152/AJPENDO.00163.2003
P577
2004-04-13T00:00:00Z